NAM-NAD+-ADO metabolic reprogramming is a key factor for DNMT3A mutation to promote leukemia development through regulating cell cycle and immune microenvironment

Yueying Wang(Changchun University of Chinese Medicine), Siqi Shang(Shanghai Jiao Tong University), Yunshuo Chen(Shanghai Jiao Tong University), Zhiyang Li(Shantou University), Xuejiao Yang(Shanghai Jiao Tong University), Xiao Wang(Qingdao University), Ying Yang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Research Square
December 13, 2022
10.21203/rs.3.rs-2352928/v1
Cited by 0

Related Papers

YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer
|Molecular Cancer|2020|383
Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis
|World Journal of Surgical Oncology|2019|276
Prognostic factors and treatment of patients with T‐cell non‐Hodgkin lymphoma
|Cancer|2005|227
The dual role of N6‐methyladenosine modification of RNAs is involved in human cancers
|Journal of Cellular and Molecular Medicine|2018|142
miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer
|Cell Death and Disease|2016|134